Close
Open Nav
Search Menu
Overview>Table>2013 BIO Convention in China Program

Click here to download the full program schedule (PDF).

*In order to accommodate the schedules of our invited keynote speakers and presenters, we have adjusted the date for this year’s BIO Convention in China. For Western attendees, the convention program and exhibition will take place November 12-13.  

Tuesday, November 12, 2013
8:00 a.m. - 5:30 p.m. Partnering Desk Opens Exhibit Hall B
9:00 a.m. - 5:25 p.m. Exhibit Floor Opens Exhibit Floor
9:00 a.m. - 10:15 a.m.
Keynote Speeches:
 Auditorium 
10:30 a.m. - 5:25 p.m. Company Presentations Rooms 406 & 407
11:00 a.m. - 11:55 a.m. Fireside Chat: Susan Herbert and Annalisa Jenkins of Merck KGaA Room 403
11:00 a.m. - 11:55 a.m.. Room 405
12:00 p.m. - 12:55 p.m.
Networking Lunch
 TBA
1:00 p.m. - 4:25 p.m. Policy Session: Roadmap to Cultivate Innovative Biologics Industry in China Room 402 A & B
1:30 p.m. - 2:25 p.m.  Fireside Chat: Wang Xiaodong, Director & Investigator, NIBS Room 403
1:30 p.m. - 2:25 p.m. Scientific Session: Dissecting China's Unmet Needs Room 405
2:30 p.m. - 2:55 p.m. Afternoon Break  
3:00 p.m. - 3:55 p.m. Fireside Chat: Dr. Henry Sun, Vice President, Tasly Holding Group & CEO of Tasly Pharmaceuticals, Inc. Room 403
3:00 p.m. - 3:55 p.m. Business Session: State of Capital Markets in US Room 405
4:30 p.m. - 5:25 p.m. CFDA/CDE Session Room 402 A & B
5:30 p.m. - 7:00 p.m. Conference Remarks and Opening Gala Reception China National Convention Center, Hall 4

 

Wednesday, November 13, 2013
8:00 a.m. - 4:30 p.m. Partnering Desk Opens Exhibit Hall B
9:00 a.m. - 4:25 p.m.  Exhibit Floor Opens Exhibit Floor
9:00 a.m. - 4:25 p.m. Company Presentations Room 406 & 407
9:00 a.m. - 10:50 a.m. Introduction & Clinical, Non-Clinical, and CRO Panels
Organized by Shanghai NewSummit Biopharma Group		 Room 403
9:30 a.m. - 10:25 a.m.  Fireside Chat: Wang Yinxiang, PhD, President, CEO, & CSO, Zhejiang Beta Pharma Room 405
10:30 a.m. - 10:55 a.m. Morning Break  
11:00 a.m. - 11:55 a.m.  Business Session: China's Private Health Care Industry Room 403
11:00 a.m. - 11:55 a.m. Scientific Session: Rare Diseases in China Room 405
12:00 p.m. - 12:55 p.m. Networking Lunch TBA
1:00 p.m. - 1:55 p.m. Business Session: Case Studies: Partnering Models Between Chinese & Western Companies Room 403
1:00 p.m. - 1:55 p.m. Business Session: Early-Stage VC Funding in China Room 405
2:10 p.m. - 4:25 p.m. China Biomedicine Clusters and Enterprises Investment and Collaboration
Organized by CIPA		 Room 403
3:00 p.m. - 3:55 p.m. Early Stage Licensing in China - Opportunities and Challenges
Presented by Mr. Amir Naiberg, YEDA/Weizmann		 Room 405
4:30 p.m. - 5:30 p.m. Closing Keynote Speeches and Reception
Sponsored by CIPA
  • ETDZ
  • James C. Greenwood, President and CEO, Biotechnology Industry Organization
  • Ren Jun, CEO, Shanghai NewSummit Biopharma Group
 Exhibit Hall B